Solesence, Inc. is expected to report Q2 2026 revenue of $14.6 million and breakeven earnings per share of $0.00, with its current $1.07 stock price reflecting a period of thin coverage and no formal analyst price targets.
Investors are primarily focused on the resolution of on-time-in-full (OTIF) shipment delays and supply chain inefficiencies that caused a significant revenue decline in the previous quarter.
The company is currently executing its “Transform and Transcend” strategic initiative, which aims to establish a 30% gross profit margin floor through operational consolidation and new technology commercialization. Shareholders are also monitoring the conversion of a reported $47 million order book into realized revenue as the company expands into the hair and scalp care segments with its patented WHSPR technology.